BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gonzalez PL, Rappo U, Akinapelli K, McGregor JS, Puttagunta S, Dunne MW. Treatment of acute bacterial skin and skin structure infection with single-dose dalbavancin in persons who inject drugs. Drugs Context 2018;7:212559. [PMID: 30574170 DOI: 10.7573/dic.212559] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Tirupathi R, Areti S, Salim SA, Palabindala V, Jonnalagadda N. Acute bacterial skin and soft tissue infections: new drugs in ID armamentarium. J Community Hosp Intern Med Perspect 2019;9:310-3. [PMID: 31528278 DOI: 10.1080/20009666.2019.1651482] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
2 Bassetti M, Labate L, Vena A, Giacobbe DR. Role or oritavancin and dalbavancin in acute bacterial skin and skin structure infections and other potential indications. Curr Opin Infect Dis 2021;34:96-108. [PMID: 33405480 DOI: 10.1097/QCO.0000000000000714] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Saldana CS, Vyas DA, Wurcel AG. Soft Tissue, Bone, and Joint Infections in People Who Inject Drugs. Infect Dis Clin North Am 2020;34:495-509. [PMID: 32782098 DOI: 10.1016/j.idc.2020.06.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Monteagudo-martínez N, Solís-garcía del Pozo J, Nava E, Ikuta I, Galindo M, Jordán J. Acute Bacterial Skin and Skin-Structure Infections, efficacy of Dalbavancin: a systematic review and meta-analysis. Expert Review of Anti-infective Therapy. [DOI: 10.1080/14787210.2021.1828865] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
5 Ritchie H, Aggarwal A, Schimmel J, Lorenzo MP. Clinical failure of dalbavancin for MRSA bacteremia in patient with severe obesity and history of IVDU. J Infect Chemother 2022:S1341-321X(21)00358-5. [PMID: 35016828 DOI: 10.1016/j.jiac.2021.12.022] [Reference Citation Analysis]
6 Soriano A, Rossolini GM, Pea F. The role of dalbavancin in the treatment of acute bacterial skin and skin structure infections (ABSSSIs). Expert Rev Anti Infect Ther 2020;18:415-22. [PMID: 32223465 DOI: 10.1080/14787210.2020.1746643] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
7 Monteagudo-Martínez N, Solís-García Del Pozo J, Ikuta I, Galindo M, Jordán J. Systematic review and meta-analysis on the safety of dalbavancin. Expert Opin Drug Saf 2021;:1-13. [PMID: 34042549 DOI: 10.1080/14740338.2021.1935864] [Reference Citation Analysis]